John Ferrari
2012
In 2012, John Ferrari earned a total compensation of $4.8M as Chief Financial Officer at United Therapeutics, a 40% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,636,616 |
|---|---|
| Non-Equity Incentive Plan | $322,059 |
| Option Awards | $2,273,625 |
| Salary | $514,800 |
| Other | $12,640 |
| Total | $4,759,740 |
Ferrari received $2.3M in option awards, accounting for 48% of the total pay in 2012.
Ferrari also received $1.6M of change in pension value and nonqualified deferred compensation earnings, $322.1K in non-equity incentive plan, $514.8K in salary and $12.6K in other compensation.
Rankings
In 2012, John Ferrari's compensation ranked 1,301st out of 11,487 executives tracked by ExecPay. In other words, Ferrari earned more than 88.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,301 out of 11,487 | 89th |
Division Manufacturing | 472 out of 4,252 | 89th |
Major group Chemicals And Allied Products | 103 out of 1,200 | 91st |
Industry group Drugs | 59 out of 922 | 94th |
Industry Pharmaceutical Preparations | 51 out of 697 | 93rd |
Source: SEC filing on April 30, 2015.
Ferrari's colleagues
We found three more compensation records of executives who worked with John Ferrari at United Therapeutics in 2012.